Replies to post #68107 on Biotech Values

[DewDiligence]

Re: AASLD (comments welcome)

>I thought we would be getting a lot more PR's and company calls. I only saw Pharmasset with a call today.<

Compared to 2007 and 2006, 2008 is a low-key AASLD; most of the sexy data have been previously released in sufficient detail to render the actual presentations anticlimactic.

The above is especially true for Telaprevir and Boceprevir—yesterday’s PR’s (in the links posted by ‘go seek’) contain few details not previously announced.

I’ll post the full Telaprevir and Boceprevir PR’s for archival purposes, and I invite comment form anyone who wishes to elaborate on how they expand on what we already knew.